We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AVCRF market cap is 4.42M. The company's latest EPS is CAD -0.0069 and P/E is -8.70.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 134k | 33k | 123k | 1.77M | 3.49M |
| Operating Income | -998k | -214k | -929k | -300k | -686k |
| Net Income | -2.11M | -1.17M | -1.71M | -818k | -701k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 208k | 440k | 2.28M | 2.57M | 2.54M |
| Total Liabilities | 673k | 1.15M | 84k | 605k | 529k |
| Total Equity | -465k | -713k | 2.2M | 1.96M | 2.01M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -687k | -1.22M | -1.24M | -438k | 660k |
| Investing | N/A | N/A | -140k | -1.21M | -1.05M |
| Financing | 616k | 1.51M | 3.09M | 254k | 42k |
| Market Cap | 4.42M |
| Price to Earnings Ratio | -8.70 |
| Price to Sales Ratio | 1.74 |
| Price to Cash Ratio | 22.22 |
| Price to Book Ratio | 3.03 |
| Dividend Yield | - |
| Shares Outstanding | 101.29M |
| Average Volume (1 week) | 12k |
| Average Volume (1 Month) | 36k |
| 52 Week Change | -56.35% |
| 52 Week High | 0.2539 |
| 52 Week Low | 0.0379 |
| Spread (Intraday) | 0.02 (32.04%) |
| Company Name | Avricore Health Inc (QB) |
| Address |
700 - 1199 west hastings street vancouver, british columbia V6E 3T5 |
| Website | https://www.avricorehealth.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
